**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 571-60-8 |1,4-Dihydroxynaphthalene | 98.0 | 209-336-4 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation.
Ingestion:
May cause digestive tract disturbances.
Inhalation:
Causes respiratory tract irritation.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
Antidote:
None reported.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or
alcohol-resistant foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Minimize dust generation and accumulation. Avoid
contact with eyes, skin, and clothing. Keep container tightly closed.
Avoid ingestion and inhalation.
Storage:
Keep container closed when not in use. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 571-60-8:
Personal Protective Equipment
Eyes:
Wear safety glasses and chemical goggles if splashing
is possible.
Skin:
Wear appropriate protective gloves and clothing to
prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Wear a NIOSH/MSHA or European Standard EN 149
approved full-facepiece airline respirator in the
positive pressure mode with emergency escape
provisions.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: brown or brown grey
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 206 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: N/A
Explosion Limits, upper: N/A
Decomposition Temperature:
Solubility in water: Soluble in hot water.
Specific Gravity/Density:
Molecular Formula: C10H8O2
Molecular Weight: 160.17
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents - strong bases.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon
dioxide, acrid smoke and fumes.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 571-60-8: QJ4730000
LD50/LC50:
Not available.
Carcinogenicity:
1,4-Dihydroxynaphthalene -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 571-60-8: No information available.
Canada
CAS# 571-60-8 is listed on Canada's DSL List.
CAS# 571-60-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 571-60-8 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 12/14/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Methyl 4-amino-3-bromobenzoate
| 106896-49-5 |
|
2,4-Dichloro-5-hydroxyaniline
| 39489-79-7 |
|
6-Chloro-4-trifluoromethoxyaniline
| 0-01-1 |
|
2,4-Dibromo-6-methylaniline
| 30273-41-7 |
|
1,4-Bis(trichloromethyl)benzene, 99%
| 68-36-0 |
|
Nicotinamide, p.a.
| 98-92-0 |
|
6-Chloro-9-(3-N-(2-chloroethyl-amino)-propylamino-2-methoxyacridine
| 17064-47-0 |
|
2-Amino-5-bromobenzotrifluoride
| 445-02-3 |
|
N,N'-p-Phenylenedimaleimide
| 3278-31-7 |
|
N,N'-m-Phenylenedimaleimide
| 3006-93-7 |
|
Allyltrimethylsilane, 97%
| 762-72-1 |
|
Celite 545
| 68855-54-9 |
|
3-Bromo-1-propanol, 97%
| 627-18-9 |
|
1,2-Epoxy-2-methylbutane
| 30095-63-7 |
|
2,3-Epoxy-2-methylbutane
| 5076-19-7 |
|
Dicyclopentadiene diepoxide
| 81-21-0 |
|
1-(3-Methylphenyl)-piperazine, 99%
| 41186-03-2 |
|
Lithium bis(trimethylsilyl)amide, 23% in methyl tert-butyl ether
| 100-41-4 |
|
Lithium bis(trimethylsilyl)amide, 20% in THF
| 100-41-4 |
|
2(2-Bromoethyl)-1,3-dioxolane, 96%
| 18742-02-4 |
|
N-(Phenylseleno)phthalimide, tech.
| 71098-88-9 |
|
Brij?? 98
| 9004-98-2 |
|
4-Fluoro-N-methylaniline
| 459-59-6 |
|
3,4,5-Trimethoxyacetophenone, 99+%
| 1136-86-3 |
|
Potassium tetracyanonickelate(II) hydrate
| 14220-17-8 |
|
Zinc peroxide, 55%
| 1314-22-3 |
|
3,4-Dimethyl-3,4-diphenylhexane
| 10192-93-5 |
|
1,4-Naphthalenediol (pract), 95% (uv-vis)
| 571-60-8 |
|
2,3-Dimethyl-2,3-diphenylbutane
| 1889-67-4 |
|
Dicumyl peroxide
| 80-43-3 |
|
Cumyl hydroperoxide
| 80-15-9 |
|
tert-Butyl cumyl peroxide
| 98-82-8 |
|
3,6,9-Triethyl-3,6,9-trimethyl-1,4,7-triperoxynonane, 41% solution in
| 24748-23-0 |
|
Di(tert-butylperoxyisopropyl)benzene
| 2212-81-9 |
|
tert-Butyl peroxy-3,5,5-trimethylhexanoate
| 13122-18-4 |
|
tert-Butylperoxy 2-ethylhexyl carbonate
| 34443-12-4 |
|
Di-tert-butyl peroxide
| 110-05-4 |
|
1,1-Di(tert-butylperoxy)cyclohexane, 50% solution in aromatic free
| 3006-86-8 |
|
Lauroyl peroxide
| 105-74-8 |
|
tert-Butyl peroxyacetate, 50% solution in aromatic free mineral
| 107-71-1 |
|
2,5-Dimethyl-2,5-di(tert-butylperoxy)hexane
| 78-63-7 |
|
2,2-Di(tert-butylperoxy)butane, 50% solution in aromatic free mineral
| 78-93-3 |
|
Benzoylformic acid, 97%
| 611-73-4 |
|
Ethyl 7-bromoheptanoate
| 29823-18-5 |
|
16-Hydroxyhexadecanoic Acid, 98%
| 506-13-8 |
|
4-(4,6-Dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride
| 0-00-0 |
|
3-Methoxysalicylic acid, 97%
| 877-22-5 |
|
d-alpha-Tocopherylquinone, 90-95%
| 7559-04-8 |
|
Dibutyl Maleate
| 105-76-0 |
|
Glutathione-Agarose, 4% cross-linked
| 0-01-1 |
|
|